Reliv International, Inc (NASDAQ:RELV) reported net sales of $17.4 million for the fourth quarter of 2013, compared with net sales of $16.9 million for the fourth quarter of 2012. U.S. net sales increased by 4.1 percent for the quarter compared with the same quarter in 2012. International net sales for the quarter decreased 1.5 percent compared to the prior-year quarter, but sales were buoyed by an increase in net sales of Europe of 30.3 percent. Reliv International, Inc (NASDAQ:RELV) shares after opening at $35.83 moved to $ on last trade day and at the end of the day closed at $1111. Company price to sales ratio in past twelve months was calculated as 11.42 and price to cash ratio as 6.62. Reliv International, Inc (NASDAQ:RELV) showed a positive weekly performance of 0.58%.
Transition Therapeutics Inc.(NASDAQ: TTHI) provided an update on the development of its drug candidates and plans for future growth. The addition of the neuropsychiatric drug candidate ELND005 has broadened the Company’s development pipeline with an un-partnered late-stage clinical asset, coupled with Transition’s core strategy of advancing assets acquired from pharmaceutical partners. Transition Therapeutics Inc (USA) (NASDAQ:TTHI) shares fell -2.99% in last trading session and ended the day on $7.78. TTHI return on equity ratio is recorded as 5.10% and its return on assets is 3.00%. Transition Therapeutics Inc (USA) (NASDAQ:TTHI) yearly performance is 57.81%.
AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced that its Annual Meeting of Shareholders will be held on Tuesday, June 10, 2014, at 9:00 a.m. PDT at the Conference Center, 4 Embarcadero Center, San Francisco, California. The Board of Directors has fixed the close of business on April 17, 2014 as the record date for determination of shareholders entitled to notice of and to vote at the Annual Meeting. American Shared Hospital Services (NYSEMKT:AMS) shares moved down -2.29% in last trading session and was closed at $2.99, while trading in range of $ 2.71 – 3.08 . American Shared Hospital Services (NYSEMKT:AMS) year to date (YTD) performance is 7.94%.
Shares of OncoGenex Pharmaceuticals (NASDAQ:OGXI) were the recipient of a large increase in short interest in January. As of March 14th, there was short interest totalling 930,484 shares, an increase of 36.1% from the February 28th total of 683,642 shares, Stock Ratings News reports. Based on an average daily volume of 382,495 shares, the short-interest ratio is presently 2.4 days. Approximately 6.7% of the company’s stock are short sold. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) weekly performance is -16.07%. On last trading day company shares ended up $9.87. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) distance from 50-day simple moving average (SMA50) is -15.24%. Analysts mean target price for the company is $25.03.